# Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment

> **NCT01419457** · PHASE1 · COMPLETED · sponsor: **MDVI, LLC** · enrollment: 36 (actual)

## Conditions studied

- Healthy
- Hepatic Impairment

## Interventions

- **DRUG:** Favipiravir
- **DRUG:** Favipiravir
- **DRUG:** Favipiravir

## Key facts

- **NCT ID:** NCT01419457
- **Lead sponsor:** MDVI, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01419457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01419457, "Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01419457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*